NB
Nanobiotix
NBTX·NASDAQParis FRFounded 2003150 employees
Micro CapbiotechPublicOncology
Platform: NBTXR3 Radioenhancer
Market Cap
$0.2B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (NBTX)
Loading NBTX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Terazanubrutinib | NBT-4735 | Phase 3 | 1 | KRASG12C | PSPET | ||
| Fixatenlimab | NBT-1923 | Phase 1/2 | 1 | CDK4/6 | Crohn's |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)